View in EDS HTML Full Text PDF Full Text

Population Pharmacokinetic Analysis to Support and Facilitate Switching from Risperidone Formulations to Rykindo in Patients with Schizophrenia.

Saved in:
Bibliographic Details
Title: Population Pharmacokinetic Analysis to Support and Facilitate Switching from Risperidone Formulations to Rykindo in Patients with Schizophrenia.
Authors: Wang W; School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, Shandong, China. wangwenyan@ytu.edu.cn.; Research and Development Center, Luye Pharma, Yantai, Shandong, China. wangwenyan@ytu.edu.cn.; National Key Laboratory of Advanced Drug Delivery and Release Systems, Yantai, Shandong, China. wangwenyan@ytu.edu.cn., Wang X; ClinPharm Solutions LLC, Chester, NJ, USA., Dong Y; Global Clinical Development, Luye Pharma (US), Ltd., Princeton, NJ, USA., Walling DP; CenExel-CNS, Garden Grove, CA, USA., Liu P; Research and Development Center, Luye Pharma, Yantai, Shandong, China.; National Key Laboratory of Advanced Drug Delivery and Release Systems, Yantai, Shandong, China., Liu W; School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, Shandong, China.; Research and Development Center, Luye Pharma, Yantai, Shandong, China.; National Key Laboratory of Advanced Drug Delivery and Release Systems, Yantai, Shandong, China., Shi Y; School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, Shandong, China.; Research and Development Center, Luye Pharma, Yantai, Shandong, China.; National Key Laboratory of Advanced Drug Delivery and Release Systems, Yantai, Shandong, China., Sun K; School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, Shandong, China. sunkx@ytu.edu.cn.; Research and Development Center, Luye Pharma, Yantai, Shandong, China. sunkx@ytu.edu.cn.; National Key Laboratory of Advanced Drug Delivery and Release Systems, Yantai, Shandong, China. sunkx@ytu.edu.cn.
Source: Neurology and therapy [Neurol Ther] 2024 Apr; Vol. 13 (2), pp. 355-372. Date of Electronic Publication: 2024 Jan 20.
Publication Type: Journal Article
Journal Info: Publisher: Springer Country of Publication: New Zealand NLM ID: 101637818 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2193-8253 (Print) Linking ISSN: 21936536 NLM ISO Abbreviation: Neurol Ther Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38244179
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Population Pharmacokinetic Analysis to Support and Facilitate Switching from Risperidone Formulations to Rykindo in Patients with Schizophrenia.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Wang+W%22">Wang W</searchLink>; School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, Shandong, China. wangwenyan@ytu.edu.cn.; Research and Development Center, Luye Pharma, Yantai, Shandong, China. wangwenyan@ytu.edu.cn.; National Key Laboratory of Advanced Drug Delivery and Release Systems, Yantai, Shandong, China. wangwenyan@ytu.edu.cn.<br /><searchLink fieldCode="AU" term="%22Wang+X%22">Wang X</searchLink>; ClinPharm Solutions LLC, Chester, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Dong+Y%22">Dong Y</searchLink>; Global Clinical Development, Luye Pharma (US), Ltd., Princeton, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Walling+DP%22">Walling DP</searchLink>; CenExel-CNS, Garden Grove, CA, USA.<br /><searchLink fieldCode="AU" term="%22Liu+P%22">Liu P</searchLink>; Research and Development Center, Luye Pharma, Yantai, Shandong, China.; National Key Laboratory of Advanced Drug Delivery and Release Systems, Yantai, Shandong, China.<br /><searchLink fieldCode="AU" term="%22Liu+W%22">Liu W</searchLink>; School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, Shandong, China.; Research and Development Center, Luye Pharma, Yantai, Shandong, China.; National Key Laboratory of Advanced Drug Delivery and Release Systems, Yantai, Shandong, China.<br /><searchLink fieldCode="AU" term="%22Shi+Y%22">Shi Y</searchLink>; School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, Shandong, China.; Research and Development Center, Luye Pharma, Yantai, Shandong, China.; National Key Laboratory of Advanced Drug Delivery and Release Systems, Yantai, Shandong, China.<br /><searchLink fieldCode="AU" term="%22Sun+K%22">Sun K</searchLink>; School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, Shandong, China. sunkx@ytu.edu.cn.; Research and Development Center, Luye Pharma, Yantai, Shandong, China. sunkx@ytu.edu.cn.; National Key Laboratory of Advanced Drug Delivery and Release Systems, Yantai, Shandong, China. sunkx@ytu.edu.cn.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101637818%22">Neurology and therapy</searchLink> [Neurol Ther] 2024 Apr; Vol. 13 (2), pp. 355-372. <i>Date of Electronic Publication: </i>2024 Jan 20.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer%22">Springer </searchLink><i>Country of Publication: </i>New Zealand <i>NLM ID: </i>101637818 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2193-8253 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221936536%22">21936536 </searchLink><i>NLM ISO Abbreviation: </i>Neurol Ther <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38244179
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s40120-024-00578-w
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 355
    Titles:
      – TitleFull: Population Pharmacokinetic Analysis to Support and Facilitate Switching from Risperidone Formulations to Rykindo in Patients with Schizophrenia.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Wang W
      – PersonEntity:
          Name:
            NameFull: Wang X
      – PersonEntity:
          Name:
            NameFull: Dong Y
      – PersonEntity:
          Name:
            NameFull: Walling DP
      – PersonEntity:
          Name:
            NameFull: Liu P
      – PersonEntity:
          Name:
            NameFull: Liu W
      – PersonEntity:
          Name:
            NameFull: Shi Y
      – PersonEntity:
          Name:
            NameFull: Sun K
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 04
              Text: 2024 Apr
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-print
              Value: 2193-8253
          Numbering:
            – Type: volume
              Value: 13
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Neurology and therapy
              Type: main
ResultId 1